Yayoi Miyazono
Japan
Case Report
High Dose Octreotide for the Treatment of Chylothorax in Three Neonates
Author(s): Makoto Saito, Tomohiro Kamoda, Daigo Kajikawa, Yayoi Miyazono, Yu Kanai, Satoshi Fujiyama, Ryoko Suzuki, Miho Takahashi-Igari, Yasuhisa Urita and Ryo SumazakiMakoto Saito, Tomohiro Kamoda, Daigo Kajikawa, Yayoi Miyazono, Yu Kanai, Satoshi Fujiyama, Ryoko Suzuki, Miho Takahashi-Igari, Yasuhisa Urita and Ryo Sumazaki
Chylothorax is an abnormal condition of lymphatic fluid collection in the pleural space, and the somatostatin analog octreotide is thought to have a beneficial effect on chylothorax. However, the octreotide dosage and administration route for chylothorax have been inconsistent to date. We report three neonatal cases of persistent chylothorax successfully treated with high-dose octreotide infusion therapy (20 μg/kg/h). Case 1 was congenital chylothorax, Case 2 was secondary chylothorax after an operation for congenital diaphragmatic hernia, and Case 3 was chylothorax after a cardiac operation. In all cases, the chylothorax was not decreased by a low-dose octreotide infusion, but after a high-dose octreotide infusion, the chylothorax decreased and eventually vanished, with no side effects.
Conclusion: We suggest that the dos.. View More»
DOI:
10.4172/2167-0897.1000218